Trial Profile
Phase I trial of fosravuconazole in patients with moderate eumycetoma
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Apr 2023
Price :
$35
*
At a glance
- Drugs Fosravuconazole (Primary)
- Indications Mycetoma
- Focus Therapeutic Use
- 30 Mar 2023 According to a DNDi media release, today announce a partnership with Eisai Co., Ltd. (Eisai) and the Mycetoma Research Center in Khartoum, Sudan in this clinical trial for patients with eumycetoma.
- 14 Sep 2015 New trial record
- 10 Sep 2015 According to an Eisai and Drugs for Neglected Diseases Initiative media release, this trial is expected to be initiated in 2016.